Cross Country Healthcare (CCRN) Proxy filing summary

Executive summary

• Announced transition from public to private ownership through acquisition by Knox Lane, a growth-oriented investment firm, with closing expected in Q3 2026.

• Transaction is structured as an all-cash deal at $13.25 per share, representing a significant premium over recent trading prices.

• No immediate changes to operations, roles, or reporting structures are planned prior to closing; business will continue as usual.

• Knox Lane aims to build on existing strengths, invest in technology, and accelerate strategic growth in healthcare staffing.

• Required approvals include shareholder and regulatory consents, with customary closing conditions.

Voting matters and shareholder proposals

• Shareholders will be asked to approve the proposed transaction at a special meeting, with proxy materials to be distributed.

• Proxy statement will include details on the transaction, participants in the solicitation, and related interests.

Board of directors and corporate governance

• Board considered expected benefits and strategic rationale in approving the transaction.

• Information on directors, executive officers, and their stock ownership is available in recent SEC filings.